Multiple myeloma companies
Timeline
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
BioSpace
May 21, 2021
BioSpace
Company Announcement Janssen received a positive CHMP opinion for DARZALEX ® SC (daratumumab and hyaluronidase-fihj) in combination with bortezomib, cyclophosphamide and dexamethasone for the treatment of adult patients with newly diagnosed systemic light-chain (AL) amyloidosis Opinion based on data from the Phase 3 ANDROMEDA (AMY3001) study CHMP also issued a positive opinion recommending DARZALEX ®
April 2, 2021
clinicaltrials.gov
Covid-19 Vaccine Responsiveness in MM and Waldenstrom - Full Text View.
DelveInsight Business Research, LLP
March 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- Rare cancers account for approximately 22% of all the diagnosed cancer cases. The US National Cancer Institute defines rare cancers as those...
Ascentage Pharma
November 23, 2020
www.prnewswire.com:443
/PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic...
May 29, 2020
BioSpace
Janssen Highlights Innovative Oncology Portfolio and Pipeline of Oral, Biologic and Cell Therapies Through ASCO20 Virtual Scientific Program - read this article along with other careers information, tips and advice on BioSpace
SHOW MORE
Industry
Cancer
